These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 8143083)
1. Results of a triple blind clinical study of myoblast transplantations without immunosuppressive treatment in young boys with Duchenne muscular dystrophy. Tremblay JP; Malouin F; Roy R; Huard J; Bouchard JP; Satoh A; Richards CL Cell Transplant; 1993; 2(2):99-112. PubMed ID: 8143083 [TBL] [Abstract][Full Text] [Related]
2. Myoblast transfer in the treatment of Duchenne's muscular dystrophy. Mendell JR; Kissel JT; Amato AA; King W; Signore L; Prior TW; Sahenk Z; Benson S; McAndrew PE; Rice R N Engl J Med; 1995 Sep; 333(13):832-8. PubMed ID: 7651473 [TBL] [Abstract][Full Text] [Related]
10. Lack of mRNA and dystrophin expression in DMD patients three months after myoblast transfer. Morandi L; Bernasconi P; Gebbia M; Mora M; Crosti F; Mantegazza R; Cornelio F Neuromuscul Disord; 1995 Jul; 5(4):291-5. PubMed ID: 7580241 [TBL] [Abstract][Full Text] [Related]
11. Normal dystrophin transcripts detected in Duchenne muscular dystrophy patients after myoblast transplantation. Gussoni E; Pavlath GK; Lanctot AM; Sharma KR; Miller RG; Steinman L; Blau HM Nature; 1992 Apr; 356(6368):435-8. PubMed ID: 1557125 [TBL] [Abstract][Full Text] [Related]
12. Successful transplantation of genetically corrected DMD myoblasts following ex vivo transduction with the dystrophin minigene. Moisset PA; Skuk D; Asselin I; Goulet M; Roy B; Karpati G; Tremblay JP Biochem Biophys Res Commun; 1998 Jun; 247(1):94-9. PubMed ID: 9636661 [TBL] [Abstract][Full Text] [Related]
13. Cell transplantation as an experimental treatment for Duchenne muscular dystrophy. Law PK; Goodwin TG; Fang Q; Deering MB; Duggirala V; Larkin C; Florendo JA; Kirby DS; Li HJ; Chen M Cell Transplant; 1993; 2(6):485-505. PubMed ID: 8167934 [TBL] [Abstract][Full Text] [Related]
15. [Therapy of Duchenne muscular dystrophy with umbilical cord blood stem cell transplantation]. Zhang C; Feng HY; Huang SL; Fang JP; Xiao LL; Yao XL; Chen C; Ye X; Zeng Y; Lu XL; Wen JM; Zhang WX; Li Z; Feng SW; Xu HG; Huang K; Zhou DH; Chen W; Xie YM; Xi J; Zhang M; Li Y; Liu Y Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Aug; 22(4):399-405. PubMed ID: 16086277 [TBL] [Abstract][Full Text] [Related]
16. Use of fluorescent latex microspheres (FLMs) to follow the fate of transplanted myoblasts. Satoh A; Huard J; Labrecque C; Tremblay JP J Histochem Cytochem; 1993 Oct; 41(10):1579-82. PubMed ID: 8245416 [TBL] [Abstract][Full Text] [Related]
17. Lymphocyte infiltration following allo- and xenomyoblast transplantation in mdx mice. Guérette B; Asselin I; Vilquin JT; Roy R; Tremblay JP Muscle Nerve; 1995 Jan; 18(1):39-51. PubMed ID: 7799997 [TBL] [Abstract][Full Text] [Related]
18. Immunocytochemical study of dystrophin in muscle cultures from patients with Duchenne muscular dystrophy and unaffected control patients. Miranda AF; Bonilla E; Martucci G; Moraes CT; Hays AP; Dimauro S Am J Pathol; 1988 Sep; 132(3):410-6. PubMed ID: 3046367 [TBL] [Abstract][Full Text] [Related]
19. Utilization of myoblasts from transgenic mice to evaluate the efficacy of myoblast transplantation. Kinoshita I; Huard J; Tremblay JP Muscle Nerve; 1994 Sep; 17(9):975-80. PubMed ID: 8065399 [TBL] [Abstract][Full Text] [Related]
20. [Clinical significance of dystrophin positive fibers in Duchenne muscular dystrophy]. Chuang YH; Jong YJ; Liu KM; Chen SS Gaoxiong Yi Xue Ke Xue Za Zhi; 1995 Jul; 11(7):409-15. PubMed ID: 7650780 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]